HYRIMOZ
Live / Registered — Registered — Section 8 accepted (as of 18 Jun 2025)
What this means for you
Registered since 16 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88204891
- Registration number
- 5804549
- Mark type
- Stylized text
- Filed
- 26 Nov 2018
- Published for opposition
- 30 Apr 2019
- Registered
- 16 Jul 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use, namely, analgesics, anti-inflammatory drugs and antipyretics
Owner
- SANDOZ AG, BASEL, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 18 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 18 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 18 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2025 — TEAS SECTION 8 RECEIVED
- 16 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 30 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Apr 2019 — PUBLISHED FOR OPPOSITION
- 10 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 22 Mar 2019 — ASSIGNED TO LIE
- 27 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Feb 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Feb 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE